B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality

Rachelle G. Veenstra, Ryan Flynn, Katharina Kreymborg, Cameron McDonald-Hyman, Asim Saha, Patricia A. Taylor, Mark J. Osborn, Angela Panoskaltsis-Mortari, Annette Schmitt-Graeff, Elisabeth Lieberknecht, William J Murphy, Jonathan S. Serody, David H. Munn, Gordon J. Freeman, James P. Allison, Tak W. Mak, Marcel Den Van Brink, Robert Zeiser, Bruce R. Blazar

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Members of the B7 family have been shown to be important for regulating immune responses by providing either positive or negative costimulatory signals. The function of B7-H3 has been controversial. We show that B7-H3 is upregulated in graft-versus-host disease (GVHD) target organs, including the colon, liver, and lung. Infusion of allogeneic donor T cells into B7-H32/2 vs wild-type (WT) recipients resulted in increased GVHD lethality associated with increased T-cell proliferation, colonic inflammatory cytokines, and destruction of epithelial barriers. Allogeneic B7-H32/2 vs WT donor T cells also had increased T-cell proliferation and GVHD lethality associated with increased proliferation and cytokine secretion in the spleen, intraepithelial lymphocyte inflammatory cytokines, and intestinal permeability. Both resting and activated regulatory T cells (Tregs) lack B7-H3 messenger RNA. Consistent with these data, GVHD was augmented in recipients of B7-H32/2 Treg-depleted grafts. In two delayed lymphocyte infusion (DLI) models, T cells lacking B7-H3 are capable of providing graft-versus-leukemia (GVL) effects. We conclude that B7-H3 is responsible for providing a negative costimulatory signal. Our studies provide support for developing and testing new therapies directed toward the B7-H3 pathway, including approaches to augment host B7-H3 early after bone marrow transplantation to prevent GVHD and to develop potent antagonistic antibodies later after transplant to facilitate DLI-mediated GVL without GVHD complications.

Original languageEnglish (US)
Pages (from-to)3335-3346
Number of pages12
JournalBlood
Volume125
Issue number21
DOIs
StatePublished - 2015

Fingerprint

T-cells
Graft vs Host Disease
Grafts
T-Lymphocytes
Transplants
Lymphocytes
Cytokines
Leukemia
Cell Proliferation
Cell proliferation
Regulatory T-Lymphocytes
Bone Marrow Transplantation
Transplantation (surgical)
Permeability
Colon
Spleen
Liver
Lung
Messenger RNA
Antibodies

Keywords

  • Absence of b7-h3 expression in allogeneic recipients or on allogeneic donor T cells leads to accelerated gvhd lethality. Increased gvhd lethality is a result of increased t-cell proliferation
  • Colon inflammatory cytokines, and intestinal permeability

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Medicine(all)
  • Hematology
  • Cell Biology

Cite this

Veenstra, R. G., Flynn, R., Kreymborg, K., McDonald-Hyman, C., Saha, A., Taylor, P. A., ... Blazar, B. R. (2015). B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality. Blood, 125(21), 3335-3346. https://doi.org/10.1182/blood-2014-09-603357

B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality. / Veenstra, Rachelle G.; Flynn, Ryan; Kreymborg, Katharina; McDonald-Hyman, Cameron; Saha, Asim; Taylor, Patricia A.; Osborn, Mark J.; Panoskaltsis-Mortari, Angela; Schmitt-Graeff, Annette; Lieberknecht, Elisabeth; Murphy, William J; Serody, Jonathan S.; Munn, David H.; Freeman, Gordon J.; Allison, James P.; Mak, Tak W.; Van Brink, Marcel Den; Zeiser, Robert; Blazar, Bruce R.

In: Blood, Vol. 125, No. 21, 2015, p. 3335-3346.

Research output: Contribution to journalArticle

Veenstra, RG, Flynn, R, Kreymborg, K, McDonald-Hyman, C, Saha, A, Taylor, PA, Osborn, MJ, Panoskaltsis-Mortari, A, Schmitt-Graeff, A, Lieberknecht, E, Murphy, WJ, Serody, JS, Munn, DH, Freeman, GJ, Allison, JP, Mak, TW, Van Brink, MD, Zeiser, R & Blazar, BR 2015, 'B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality', Blood, vol. 125, no. 21, pp. 3335-3346. https://doi.org/10.1182/blood-2014-09-603357
Veenstra, Rachelle G. ; Flynn, Ryan ; Kreymborg, Katharina ; McDonald-Hyman, Cameron ; Saha, Asim ; Taylor, Patricia A. ; Osborn, Mark J. ; Panoskaltsis-Mortari, Angela ; Schmitt-Graeff, Annette ; Lieberknecht, Elisabeth ; Murphy, William J ; Serody, Jonathan S. ; Munn, David H. ; Freeman, Gordon J. ; Allison, James P. ; Mak, Tak W. ; Van Brink, Marcel Den ; Zeiser, Robert ; Blazar, Bruce R. / B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality. In: Blood. 2015 ; Vol. 125, No. 21. pp. 3335-3346.
@article{90437ec2289a480ea837ea4ae011e3be,
title = "B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality",
abstract = "Members of the B7 family have been shown to be important for regulating immune responses by providing either positive or negative costimulatory signals. The function of B7-H3 has been controversial. We show that B7-H3 is upregulated in graft-versus-host disease (GVHD) target organs, including the colon, liver, and lung. Infusion of allogeneic donor T cells into B7-H32/2 vs wild-type (WT) recipients resulted in increased GVHD lethality associated with increased T-cell proliferation, colonic inflammatory cytokines, and destruction of epithelial barriers. Allogeneic B7-H32/2 vs WT donor T cells also had increased T-cell proliferation and GVHD lethality associated with increased proliferation and cytokine secretion in the spleen, intraepithelial lymphocyte inflammatory cytokines, and intestinal permeability. Both resting and activated regulatory T cells (Tregs) lack B7-H3 messenger RNA. Consistent with these data, GVHD was augmented in recipients of B7-H32/2 Treg-depleted grafts. In two delayed lymphocyte infusion (DLI) models, T cells lacking B7-H3 are capable of providing graft-versus-leukemia (GVL) effects. We conclude that B7-H3 is responsible for providing a negative costimulatory signal. Our studies provide support for developing and testing new therapies directed toward the B7-H3 pathway, including approaches to augment host B7-H3 early after bone marrow transplantation to prevent GVHD and to develop potent antagonistic antibodies later after transplant to facilitate DLI-mediated GVL without GVHD complications.",
keywords = "Absence of b7-h3 expression in allogeneic recipients or on allogeneic donor T cells leads to accelerated gvhd lethality. Increased gvhd lethality is a result of increased t-cell proliferation, Colon inflammatory cytokines, and intestinal permeability",
author = "Veenstra, {Rachelle G.} and Ryan Flynn and Katharina Kreymborg and Cameron McDonald-Hyman and Asim Saha and Taylor, {Patricia A.} and Osborn, {Mark J.} and Angela Panoskaltsis-Mortari and Annette Schmitt-Graeff and Elisabeth Lieberknecht and Murphy, {William J} and Serody, {Jonathan S.} and Munn, {David H.} and Freeman, {Gordon J.} and Allison, {James P.} and Mak, {Tak W.} and {Van Brink}, {Marcel Den} and Robert Zeiser and Blazar, {Bruce R.}",
year = "2015",
doi = "10.1182/blood-2014-09-603357",
language = "English (US)",
volume = "125",
pages = "3335--3346",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "21",

}

TY - JOUR

T1 - B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality

AU - Veenstra, Rachelle G.

AU - Flynn, Ryan

AU - Kreymborg, Katharina

AU - McDonald-Hyman, Cameron

AU - Saha, Asim

AU - Taylor, Patricia A.

AU - Osborn, Mark J.

AU - Panoskaltsis-Mortari, Angela

AU - Schmitt-Graeff, Annette

AU - Lieberknecht, Elisabeth

AU - Murphy, William J

AU - Serody, Jonathan S.

AU - Munn, David H.

AU - Freeman, Gordon J.

AU - Allison, James P.

AU - Mak, Tak W.

AU - Van Brink, Marcel Den

AU - Zeiser, Robert

AU - Blazar, Bruce R.

PY - 2015

Y1 - 2015

N2 - Members of the B7 family have been shown to be important for regulating immune responses by providing either positive or negative costimulatory signals. The function of B7-H3 has been controversial. We show that B7-H3 is upregulated in graft-versus-host disease (GVHD) target organs, including the colon, liver, and lung. Infusion of allogeneic donor T cells into B7-H32/2 vs wild-type (WT) recipients resulted in increased GVHD lethality associated with increased T-cell proliferation, colonic inflammatory cytokines, and destruction of epithelial barriers. Allogeneic B7-H32/2 vs WT donor T cells also had increased T-cell proliferation and GVHD lethality associated with increased proliferation and cytokine secretion in the spleen, intraepithelial lymphocyte inflammatory cytokines, and intestinal permeability. Both resting and activated regulatory T cells (Tregs) lack B7-H3 messenger RNA. Consistent with these data, GVHD was augmented in recipients of B7-H32/2 Treg-depleted grafts. In two delayed lymphocyte infusion (DLI) models, T cells lacking B7-H3 are capable of providing graft-versus-leukemia (GVL) effects. We conclude that B7-H3 is responsible for providing a negative costimulatory signal. Our studies provide support for developing and testing new therapies directed toward the B7-H3 pathway, including approaches to augment host B7-H3 early after bone marrow transplantation to prevent GVHD and to develop potent antagonistic antibodies later after transplant to facilitate DLI-mediated GVL without GVHD complications.

AB - Members of the B7 family have been shown to be important for regulating immune responses by providing either positive or negative costimulatory signals. The function of B7-H3 has been controversial. We show that B7-H3 is upregulated in graft-versus-host disease (GVHD) target organs, including the colon, liver, and lung. Infusion of allogeneic donor T cells into B7-H32/2 vs wild-type (WT) recipients resulted in increased GVHD lethality associated with increased T-cell proliferation, colonic inflammatory cytokines, and destruction of epithelial barriers. Allogeneic B7-H32/2 vs WT donor T cells also had increased T-cell proliferation and GVHD lethality associated with increased proliferation and cytokine secretion in the spleen, intraepithelial lymphocyte inflammatory cytokines, and intestinal permeability. Both resting and activated regulatory T cells (Tregs) lack B7-H3 messenger RNA. Consistent with these data, GVHD was augmented in recipients of B7-H32/2 Treg-depleted grafts. In two delayed lymphocyte infusion (DLI) models, T cells lacking B7-H3 are capable of providing graft-versus-leukemia (GVL) effects. We conclude that B7-H3 is responsible for providing a negative costimulatory signal. Our studies provide support for developing and testing new therapies directed toward the B7-H3 pathway, including approaches to augment host B7-H3 early after bone marrow transplantation to prevent GVHD and to develop potent antagonistic antibodies later after transplant to facilitate DLI-mediated GVL without GVHD complications.

KW - Absence of b7-h3 expression in allogeneic recipients or on allogeneic donor T cells leads to accelerated gvhd lethality. Increased gvhd lethality is a result of increased t-cell proliferation

KW - Colon inflammatory cytokines, and intestinal permeability

UR - http://www.scopus.com/inward/record.url?scp=84979860701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979860701&partnerID=8YFLogxK

U2 - 10.1182/blood-2014-09-603357

DO - 10.1182/blood-2014-09-603357

M3 - Article

C2 - 25814530

AN - SCOPUS:84979860701

VL - 125

SP - 3335

EP - 3346

JO - Blood

JF - Blood

SN - 0006-4971

IS - 21

ER -